Algernon Pharmaceuticals Inc appoints two consultants for its DMT stroke clinical program; completes manufacturing supply for trials
UK-based Dr. Anthony Rudd and Dr. Robert Simister have been named as consultants for its DMT stroke clinical research program, of which the...
Source: proactiveinvestors.com